Innovex International, Inc. INVX
28.50
(0.06)
(0.21%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 32.0×
Follow INVX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
12.61 | 18.23 | 32.52 | 27.87 |
P/S ratio |
1.34 | 1.54 | 1.72 | 1.71 | |
P/FCF ratio |
5.29 | 5.90 | 6.86 | 7.71 | |
P/Operating CF |
26.37 | 28.89 | 84.75 | 46.08 | |
P/B ratio |
1.23 | 1.43 | 1.63 | 1.61 | |
Price to Tangible BV |
1.55 | 1.79 | 2.05 | 2.04 | |
EV/Sales |
1.19 | 1.36 | 1.54 | 1.51 | |
EV/EBITDA |
5.60 | 6.46 | 9.17 | 8.54 | |
EV/Operating CF |
6.51 | 6.97 | 8.38 | 9.58 | |
EV/FCF |
4.73 | 5.20 | 6.14 | 6.82 | |
Quick Ratio |
2.58 | 2.98 | 3.02 | 2.93 | |
Current Ratio |
4.78 | 4.91 | 5.10 | 5.01 | |
Net Debt/EBITDA |
(1.69) | (3.99) | 78.13 | (3.69) | |
Debt/Assets |
2.11% | 2.02% | 1.88% | 1.89% | |
Debt/Equity |
0.03 | 0.02 | 0.02 | 0.02 | |
Asset Turnover |
0.80 | 0.79 | 0.79 | 0.78 | |
Operating CF/Net income |
1.23 | 3.74 | (1.19) | 1.48 | |
Capex/Depreciation |
4.18 | (0.40) | (0.29) | (0.06) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.82% | 11.71% | 17.47% | 15.96% | |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.16 | 0.17 | |
Share Based Compensation of Revenue |
1.35% | 1.84% | 1.24% | 1.38% | |
Graham Net Nets |
0.39 | 0.34 | 0.30 | 0.30 | |
Graham Number |
22.35 | 20.34 | 15.89 | 17.55 | |
Earnings Yield |
7.93% | 5.49% | 3.08% | 3.59% | |
Free Cash Flow Yield |
18.89% | 16.95% | 14.57% | 12.97% | |
Revenue per Share |
3.49 | 3.96 | 3.47 | 3.56 | |
Operating CF per Share |
0.70 | 0.76 | 0.29 | 0.54 | |
Capex per Share |
1.13 | (0.11) | (0.08) | (0.02) | |
Free Cash Flow per Share |
1.84 | 0.65 | 0.21 | 0.52 | |
Cash per Share |
2.37 | 2.95 | 2.91 | 3.23 | |
Shareholders Equity per Share |
15.10 | 15.33 | 14.95 | 15.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
15.10 | 15.33 | 14.95 | 15.39 | |
Free Cash Flow |
126.43 | 44.78 | 14.22 | 35.85 | |
Working Capital |
561.64 | 579.88 | 605.13 | 631.01 | |
Capital Expenditures |
78.06 | (7.46) | (5.62) | (1.18) | |
Net Current Asset Value |
495.40 | 517.44 | 496.12 | 519.28 | |
EV/EBIT |
8.52 | 10.04 | 16.92 | 15.09 | |
Capex to Sales |
(0.33) | 0.03 | 0.02 | 0.00 | |
Net Profit Margin |
16.35% | 5.11% | (6.97%) | 10.22% | |
Price to Operating Income |
9.54 | 11.38 | 18.90 | 17.06 | |
| Other line items | |||||
Average Receivables |
222.74 | 238.64 | 240.83 | 230.53 | |
Average Payables |
75.12 | 62.96 | 75.64 | 71.25 | |
Average Inventory |
286.36 | 259.80 | 261.12 | 271.67 | |
Average Assets |
1,193.35 | 1,232.90 | 1,241.84 | 1,277.41 | |
Average Common Equity |
971.65 | 1,007.93 | 1,004.64 | 1,027.03 |
Columns are period end dates